Performance analysis of Cartesian Therapeutics (RNAC)
Annual Return
Over the past 3 years, RNAC has had an average annual return of -38.43%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, RNAC has had an average annual return of -39.55%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, RNAC has had an average annual return of -32.48%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jun 22, 2016, RNAC has had an average annual return of -32.36%, underperforming the benchmark SPY, which returned +15.36% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +12.79% | -59.62% | -13.41% | -39.03% | -65.35% | +7.62% | +27.29% | -10.53% | -72.88% | -42.80% | +22.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.23% | +11.04% | -19.34% | +1.37% | +21.62% | +37.78% | -21.77% | +12.79% | |||||
| 2025 | +7.98% | -2.39% | -30.07% | -8.92% | -20.28% | +8.33% | +23.48% | -21.64% | +1.67% | -19.75% | -8.72% | -3.37% | -59.62% |
| 2024 | +4.47% | +1.75% | -11.28% | +13.15% | +57.52% | -22.25% | -39.66% | -14.43% | +15.66% | +22.66% | -4.88% | -4.91% | -13.41% |
| 2023 | +56.63% | -7.91% | -14.69% | -14.40% | -0.82% | -5.10% | -2.63% | +12.84% | -13.88% | +17.97% | +7.95% | -48.96% | -39.03% |
| 2022 | -23.31% | -26.04% | -33.46% | -37.77% | +15.17% | +48.57% | +21.37% | +18.22% | -12.81% | -3.59% | -17.09% | -13.78% | -65.35% |
| 2021 | +32.02% | +5.50% | +7.23% | -33.69% | +44.66% | -3.68% | -17.25% | +25.46% | -4.16% | -13.70% | -16.42% | +8.68% | +7.62% |
| 2020 | +51.24% | +11.12% | -39.76% | +12.09% | +35.87% | -22.59% | -16.21% | +9.24% | -4.63% | +19.37% | +13.53% | -9.83% | +27.29% |
| 2019 | -41.00% | +26.76% | +19.14% | -9.27% | -7.49% | -9.99% | +0.55% | -1.17% | -1.65% | -16.00% | +11.52% | +45.18% | -10.53% |
| 2018 | -6.82% | +0.21% | +11.25% | +15% | +2.14% | +10.69% | -8.60% | +11.98% | +14.67% | -66.95% | +17.32% | -55.89% | -72.88% |
| 2017 | -18.37% | -6.57% | +9.48% | -15.79% | +13.43% | +45.18% | -14.20% | +4.76% | +2.24% | +16.27% | -49.77% | -7.97% | -42.80% |
Drawdown analysis of Cartesian Therapeutics (RNAC)
The maximum drawdown for the RNAC was -99.26%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current RNAC drawdown is -98.97%.
Since Jun 22, 2016 RNAC has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.26% | Nov 25, 2016 | 2345 | Mar 27, 2026 | Ongoing | Ongoing | Ongoing |
| -24.79% | Jul 13, 2016 | 20 | Aug 10, 2016 | 29 | Sep 21, 2016 | 49 |
| -16.26% | Sep 26, 2016 | 8 | Oct 6, 2016 | 8 | Oct 18, 2016 | 16 |
| -7.33% | Nov 11, 2016 | 2 | Nov 15, 2016 | 5 | Nov 22, 2016 | 7 |
| -5.48% | Oct 19, 2016 | 3 | Oct 24, 2016 | 5 | Oct 31, 2016 | 8 |
| -2.75% | Nov 8, 2016 | 1 | Nov 9, 2016 | 1 | Nov 10, 2016 | 2 |
| -2.49% | Sep 21, 2016 | 1 | Sep 22, 2016 | 1 | Sep 23, 2016 | 2 |
| -1.34% | Nov 3, 2016 | 1 | Nov 4, 2016 | 1 | Nov 7, 2016 | 2 |
| -0.36% | Jul 8, 2016 | 1 | Jul 11, 2016 | 2 | Jul 13, 2016 | 3 |
| -0.28% | Jun 23, 2016 | 2 | Jun 27, 2016 | 8 | Jul 8, 2016 | 10 |